Do analysts rate BNBX or AWX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Applied Dna Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Avalon 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is BNBX or AWX more profitable?

Avalon has a net margin of 1.17% compared to Applied Dna Sciences' net margin of -1,647.25%. Avalon's return on equity of 2.72% beat Applied Dna Sciences' return on equity. Company Net Margins Return on Equity Return on Assets Applied Dna Sciences -1,647.25% -349.95% -283.96% Avalon 1.17% 2.72% 1.10%

Do analysts recommend BNBX or GFAI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Applied Dna Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Guardforce AI 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, BNBX or GFAI?

Guardforce AI has higher revenue and earnings than Applied Dna Sciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Applied Dna Sciences $2.14M 1.17 -$15.16M -$36.76 N/A Guardforce AI $35.23M 0.27 -$6.66M N/A N/A

Do analysts prefer BNBX or OFAL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Applied Dna Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 OFA Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation & earnings, BNBX or OFAL?

OFA Group has lower revenue, but higher earnings than Applied Dna Sciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Applied Dna Sciences $2.14M 1.17 -$15.16M -$36.76 N/A OFA Group $710.64K 11.52 -$710K N/A N/A

Do analysts rate BNBX or SFHG?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Applied Dna Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Samfine Creation Holdings Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation and earnings, BNBX or SFHG?

Samfine Creation Holdings Group has higher revenue and earnings than Applied Dna Sciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Applied Dna Sciences $2.14M 1.17 -$15.16M -$36.76 N/A Samfine Creation Holdings Group $21.82M 0.48 -$2.55M N/A N/A

Do analysts prefer TC or BNBX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Token Cat 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Applied Dna Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation and earnings, TC or BNBX?

Token Cat has higher earnings, but lower revenue than Applied Dna Sciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Token Cat $850K 4.66 $320K N/A N/A Applied Dna Sciences $2.14M 1.17 -$15.16M -$36.76 N/A

Applied Dna Sciences (BNBX) Competitors

$0.35 -0.01 (-3.61%)

As of 12:09 PM Eastern

Compare

BNBX vs. AWX, GFAI, OFAL, SFHG, and TC

Should you buy Applied Dna Sciences stock or one of its competitors? MarketBeat compares Applied Dna Sciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Applied Dna Sciences include Avalon (AWX), Guardforce AI (GFAI), OFA Group (OFAL), Samfine Creation Holdings Group (SFHG), and Token Cat (TC). These companies are all part of the "business services" industry.

How does Applied Dna Sciences compare to Avalon?

Applied Dna Sciences (NASDAQ:BNBX) and Avalon (NYSE:AWX) are both small-cap business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, analyst recommendations, profitability and dividends.

Avalon has higher revenue and earnings than Applied Dna Sciences. Applied Dna Sciences is trading at a lower price-to-earnings ratio than Avalon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Applied Dna Sciences	$2.14M	1.17	-$15.16M	-$36.76	N/A
Avalon	$85.14M	0.12	-$1.77M	$0.15	16.87

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Applied Dna Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Avalon	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Avalon had 1 more articles in the media than Applied Dna Sciences. MarketBeat recorded 1 mentions for Avalon and 0 mentions for Applied Dna Sciences. Applied Dna Sciences' average media sentiment score of 0.00 equaled Avalon'saverage media sentiment score.

Company	Overall Sentiment
Applied Dna Sciences	Neutral
Avalon	Neutral

Applied Dna Sciences has a beta of 0.52, indicating that its share price is 48% less volatile than the broader market. Comparatively, Avalon has a beta of 0.62, indicating that its share price is 38% less volatile than the broader market.

22.2% of Applied Dna Sciences shares are held by institutional investors. Comparatively, 34.4% of Avalon shares are held by institutional investors. 6.1% of Applied Dna Sciences shares are held by insiders. Comparatively, 20.0% of Avalon shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Avalon has a net margin of 1.17% compared to Applied Dna Sciences' net margin of -1,647.25%. Avalon's return on equity of 2.72% beat Applied Dna Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Applied Dna Sciences	-1,647.25%	-349.95%	-283.96%
Avalon	1.17%	2.72%	1.10%

Summary

Avalon beats Applied Dna Sciences on 11 of the 13 factors compared between the two stocks.

How does Applied Dna Sciences compare to Guardforce AI?

Applied Dna Sciences (NASDAQ:BNBX) and Guardforce AI (NASDAQ:GFAI) are both small-cap business services companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, media sentiment, institutional ownership, analyst recommendations, dividends and risk.

22.2% of Applied Dna Sciences shares are owned by institutional investors. Comparatively, 2.0% of Guardforce AI shares are owned by institutional investors. 6.1% of Applied Dna Sciences shares are owned by company insiders. Comparatively, 76.7% of Guardforce AI shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Applied Dna Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Guardforce AI	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Guardforce AI has a net margin of 0.00% compared to Applied Dna Sciences' net margin of -1,647.25%. Guardforce AI's return on equity of 0.00% beat Applied Dna Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Applied Dna Sciences	-1,647.25%	-349.95%	-283.96%
Guardforce AI	N/A	N/A	N/A

In the previous week, Guardforce AI had 1 more articles in the media than Applied Dna Sciences. MarketBeat recorded 1 mentions for Guardforce AI and 0 mentions for Applied Dna Sciences. Guardforce AI's average media sentiment score of 0.63 beat Applied Dna Sciences' score of 0.00 indicating that Guardforce AI is being referred to more favorably in the news media.

Company	Overall Sentiment
Applied Dna Sciences	Neutral
Guardforce AI	Positive

Guardforce AI has higher revenue and earnings than Applied Dna Sciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Applied Dna Sciences	$2.14M	1.17	-$15.16M	-$36.76	N/A
Guardforce AI	$35.23M	0.27	-$6.66M	N/A	N/A

Applied Dna Sciences has a beta of 0.52, indicating that its share price is 48% less volatile than the broader market. Comparatively, Guardforce AI has a beta of 2.56, indicating that its share price is 156% more volatile than the broader market.

Summary

Guardforce AI beats Applied Dna Sciences on 9 of the 11 factors compared between the two stocks.

How does Applied Dna Sciences compare to OFA Group?

Applied Dna Sciences (NASDAQ:BNBX) and OFA Group (NASDAQ:OFAL) are both small-cap business services companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, valuation, profitability, media sentiment, analyst recommendations, earnings, institutional ownership and dividends.

OFA Group has a net margin of 0.00% compared to Applied Dna Sciences' net margin of -1,647.25%. OFA Group's return on equity of 0.00% beat Applied Dna Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Applied Dna Sciences	-1,647.25%	-349.95%	-283.96%
OFA Group	N/A	N/A	N/A

22.2% of Applied Dna Sciences shares are owned by institutional investors. 6.1% of Applied Dna Sciences shares are owned by company insiders. Comparatively, 56.0% of OFA Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, OFA Group had 1 more articles in the media than Applied Dna Sciences. MarketBeat recorded 1 mentions for OFA Group and 0 mentions for Applied Dna Sciences. Applied Dna Sciences' average media sentiment score of 0.00 beat OFA Group's score of -0.71 indicating that Applied Dna Sciences is being referred to more favorably in the media.

Company	Overall Sentiment
Applied Dna Sciences	Neutral
OFA Group	Negative

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Applied Dna Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
OFA Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

OFA Group has lower revenue, but higher earnings than Applied Dna Sciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Applied Dna Sciences	$2.14M	1.17	-$15.16M	-$36.76	N/A
OFA Group	$710.64K	11.52	-$710K	N/A	N/A

Applied Dna Sciences has a beta of 0.52, meaning that its stock price is 48% less volatile than the broader market. Comparatively, OFA Group has a beta of 0.85, meaning that its stock price is 15% less volatile than the broader market.

Summary

OFA Group beats Applied Dna Sciences on 8 of the 11 factors compared between the two stocks.

How does Applied Dna Sciences compare to Samfine Creation Holdings Group?

Applied Dna Sciences (NASDAQ:BNBX) and Samfine Creation Holdings Group (NASDAQ:SFHG) are both small-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership.

In the previous week, Applied Dna Sciences' average media sentiment score of 0.00 equaled Samfine Creation Holdings Group'saverage media sentiment score.

Company	Overall Sentiment
Applied Dna Sciences	Neutral
Samfine Creation Holdings Group	Neutral

Samfine Creation Holdings Group has a net margin of 0.00% compared to Applied Dna Sciences' net margin of -1,647.25%. Samfine Creation Holdings Group's return on equity of 0.00% beat Applied Dna Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Applied Dna Sciences	-1,647.25%	-349.95%	-283.96%
Samfine Creation Holdings Group	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Applied Dna Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Samfine Creation Holdings Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Samfine Creation Holdings Group has higher revenue and earnings than Applied Dna Sciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Applied Dna Sciences	$2.14M	1.17	-$15.16M	-$36.76	N/A
Samfine Creation Holdings Group	$21.82M	0.48	-$2.55M	N/A	N/A

Applied Dna Sciences has a beta of 0.52, meaning that its stock price is 48% less volatile than the broader market. Comparatively, Samfine Creation Holdings Group has a beta of 2.08, meaning that its stock price is 108% more volatile than the broader market.

22.2% of Applied Dna Sciences shares are held by institutional investors. 6.1% of Applied Dna Sciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Samfine Creation Holdings Group beats Applied Dna Sciences on 6 of the 9 factors compared between the two stocks.

How does Applied Dna Sciences compare to Token Cat?

Token Cat (NASDAQ:TC) and Applied Dna Sciences (NASDAQ:BNBX) are both small-cap business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations, dividends and media sentiment.

Token Cat has a beta of 0.76, indicating that its share price is 24% less volatile than the broader market. Comparatively, Applied Dna Sciences has a beta of 0.52, indicating that its share price is 48% less volatile than the broader market.

8.9% of Token Cat shares are owned by institutional investors. Comparatively, 22.2% of Applied Dna Sciences shares are owned by institutional investors. 0.5% of Token Cat shares are owned by company insiders. Comparatively, 6.1% of Applied Dna Sciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Token Cat	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Applied Dna Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Token Cat has a net margin of 0.00% compared to Applied Dna Sciences' net margin of -1,647.25%. Token Cat's return on equity of 0.00% beat Applied Dna Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Token Cat	N/A	N/A	N/A
Applied Dna Sciences	-1,647.25%	-349.95%	-283.96%

Token Cat has higher earnings, but lower revenue than Applied Dna Sciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Token Cat	$850K	4.66	$320K	N/A	N/A
Applied Dna Sciences	$2.14M	1.17	-$15.16M	-$36.76	N/A

In the previous week, Token Cat had 17 more articles in the media than Applied Dna Sciences. MarketBeat recorded 17 mentions for Token Cat and 0 mentions for Applied Dna Sciences. Token Cat's average media sentiment score of 0.00 equaled Applied Dna Sciences'average media sentiment score.

Company	Overall Sentiment
Token Cat	Neutral
Applied Dna Sciences	Neutral

Summary

Token Cat beats Applied Dna Sciences on 7 of the 10 factors compared between the two stocks.

Get Applied Dna Sciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BNBX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BNBX vs. The Competition

Export

Metric	Applied Dna Sciences	Services – Research, Development, Testing Labs Industry	Services Sector	NASDAQ Exchange
Market Cap	$2.50M	$8.90M	$23.06B	$12.45B
Dividend Yield	N/A	N/A	5.23%	6.52%
P/E Ratio	-0.01	N/A	18.73	24.48
Price / Sales	1.17	2.53	37.82	95.01
Price / Cash	N/A	N/A	57.86	49.23
Price / Book	0.23	0.23	12.46	6.43
Net Income	-$15.16M	-$15.16M	-$15.27M	$335.81M
7 Day Performance	-0.94%	1.83%	-0.87%	1.08%
1 Month Performance	-35.86%	-20.97%	4.52%	4.89%
1 Year Performance	N/A	N/A	-22.07%	25.11%

Applied Dna Sciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BNBX Applied Dna Sciences	0.8072 of 5 stars	$0.35 -3.6%	N/A	N/A	$2.50M	$2.14M	N/A	70	Gap Down
AWX Avalon	N/A	$2.51 +0.6%	N/A	+5.0%	$9.77M	$85.14M	10.02	610
GFAI Guardforce AI	0.5203 of 5 stars	$0.40 +0.5%	N/A	-66.5%	$9.74M	$35.23M	N/A	1,604
OFAL OFA Group	1.1352 of 5 stars	$0.19 +3.4%	N/A	-91.1%	$8.93M	$200K	N/A	6
SFHG Samfine Creation Holdings Group	0.1325 of 5 stars	$2.17 +2.4%	N/A	-35.0%	$8.81M	$21.82M	N/A	N/A	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BNBX) was last updated on 7/7/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Applied Dna Sciences (BNBX) Competitors

BNBX vs. AWX, GFAI, OFAL, SFHG, and TC

How does Applied Dna Sciences compare to Avalon?

Summary

How does Applied Dna Sciences compare to Guardforce AI?

Summary

How does Applied Dna Sciences compare to OFA Group?

Summary

How does Applied Dna Sciences compare to Samfine Creation Holdings Group?

Summary

How does Applied Dna Sciences compare to Token Cat?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BNBX vs. The Competition

Applied Dna Sciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Applied Dna Sciences (BNBX) Competitors

BNBX vs. AWX, GFAI, OFAL, SFHG, and TC

How does Applied Dna Sciences compare to Avalon?

Which has stronger valuation and earnings, BNBX or AWX?

Do analysts rate BNBX or AWX?

Does the media refer more to BNBX or AWX?

Which has more risk and volatility, BNBX or AWX?

Do insiders and institutionals believe in BNBX or AWX?

Is BNBX or AWX more profitable?

Summary

How does Applied Dna Sciences compare to Guardforce AI?

Do institutionals & insiders believe in BNBX or GFAI?

Do analysts recommend BNBX or GFAI?

Is BNBX or GFAI more profitable?

Does the media refer more to BNBX or GFAI?

Which has preferable valuation & earnings, BNBX or GFAI?

Which has more volatility & risk, BNBX or GFAI?

Summary

How does Applied Dna Sciences compare to OFA Group?

Is BNBX or OFAL more profitable?

Do institutionals & insiders hold more shares of BNBX or OFAL?

Does the media favor BNBX or OFAL?

Do analysts prefer BNBX or OFAL?

Which has higher valuation & earnings, BNBX or OFAL?

Which has more volatility & risk, BNBX or OFAL?

Summary

How does Applied Dna Sciences compare to Samfine Creation Holdings Group?

Does the media prefer BNBX or SFHG?

Is BNBX or SFHG more profitable?

Do analysts rate BNBX or SFHG?

Which has preferable valuation and earnings, BNBX or SFHG?

Which has more risk and volatility, BNBX or SFHG?

Do institutionals and insiders have more ownership in BNBX or SFHG?

Summary

How does Applied Dna Sciences compare to Token Cat?

Which has more risk and volatility, TC or BNBX?

Do institutionals and insiders believe in TC or BNBX?

Do analysts prefer TC or BNBX?

Is TC or BNBX more profitable?

Which has higher valuation and earnings, TC or BNBX?

Does the media favor TC or BNBX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BNBX vs. The Competition

Applied Dna Sciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools